期刊论文详细信息
Frontiers in Oncology
Preoperative prediction model for macrotrabecular-massive hepatocellular carcinoma based on contrast-enhanced CT and clinical characteristics: a retrospective study
Oncology
Wenshuang Ding1  Yue Zhao2  Chutong He3  Xinhua Wei3  Wanli Zhang3  Nianhua Wang3  Xinqing Jiang3  Jiamin Li3  Ruimeng Yang3  Ye Wang3  Wang Yao3 
[1] Department of Pathology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China;Department of Radiology, Central People’s Hospital of Zhanjiang, Zhanjiang, Guangdong, China;Department of Radiology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China;
关键词: hepatocellular carcinoma;    liver neoplasm;    computed tomography;    macrotrabecular-massive;    diagnosis;   
DOI  :  10.3389/fonc.2023.1124069
 received in 2022-12-14, accepted in 2023-04-18,  发布年份 2023
来源: Frontiers
PDF
【 摘 要 】

ObjectiveTo investigate the predictive value of contrast-enhanced computed tomography (CECT) imaging features and clinical factors in identifying the macrotrabecular-massive (MTM) subtype of hepatocellular carcinoma (HCC) preoperatively.MethodsThis retrospective study included 101 consecutive patients with pathology-proven HCC (35 MTM subtype vs. 66 non-MTM subtype) who underwent liver surgery and preoperative CECT scans from January 2017 to November 2021. The imaging features were evaluated by two board-certified abdominal radiologists independently. The clinical characteristics and imaging findings were compared between the MTM and non-MTM subtypes. Univariate and multivariate logistic regression analyses were performed to investigate the association of clinical-radiological variables and MTM-HCCs and develop a predictive model. Subgroup analysis was also performed in BCLC 0-A stage patients. Receiver operating characteristic (ROC) curves analysis was used to determine the optimal cutoff values and the area under the curve (AUC) was employed to evaluate predictive performance.ResultsIntratumor hypoenhancement (odds ratio [OR] = 2.724; 95% confidence interval [CI]: 1.033, 7.467; p = .045), tumors without enhancing capsules (OR = 3.274; 95% CI: 1.209, 9.755; p = .03), high serum alpha-fetoprotein (AFP) (≥ 228 ng/mL, OR = 4.101; 95% CI: 1.523, 11.722; p = .006) and high hemoglobin (≥ 130.5 g/L; OR = 3.943; 95% CI: 1.466, 11.710; p = .009) were independent predictors for MTM-HCCs. The clinical-radiologic (CR) model showed the best predictive performance, achieving an AUC of 0.793, sensitivity of 62.9% and specificity of 81.8%. The CR model also effectively identify MTM-HCCs in early-stage (BCLC 0-A stage) patients.ConclusionCombining CECT imaging features and clinical characteristics is an effective method for preoperatively identifying MTM-HCCs, even in early-stage patients. The CR model has high predictive performance and could potentially help guide decision-making regarding aggressive therapies in MTM-HCC patients.

【 授权许可】

Unknown   
Copyright © 2023 He, Zhang, Zhao, Li, Wang, Yao, Wang, Ding, Wei, Yang and Jiang

【 预 览 】
附件列表
Files Size Format View
RO202310101762602ZK.pdf 11129KB PDF download
  文献评价指标  
  下载次数:68次 浏览次数:4次